The present invention relates to parenteral formulations for certain long chain saturated and monounsaturated fatty acid derivatives of 1 ß D arabinofuranosylcytosine (cytarabine). In particular the present invention relates to a parenteral pharmaceutical composition and a method of the preparation thereof in order to accommodate therapeutically effective doses of the said derivatives ameliorating compliance in treatment of cancer.
